A Phase II Study to Evaluate Lenalidomide in Combination With Metronomic-Dose Cyclophosphamide in Patients With Heavily Pretreated Classical Hodgkin Lymphoma
Acta Oncologica - United Kingdom
doi 10.3109/0284186x.2015.1007212
Full Text
Open PDFAbstract
Available in full text
Date
March 3, 2015
Authors
Publisher
Informa UK Limited